An interventional study of questionnaire administration and cognitive assessment in Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Ziekenhuis Netwerk Antwerpen (ZNA). Status unknown at 4 sites in Belgium. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2013-05-15.
Sponsored by Ziekenhuis Netwerk Antwerpen (ZNA) · Not applicable, Interventional, and Supportive care
RATIONALE: Questionnaires that measure how well older patients think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer.
PURPOSE: This clinical trial is studying testing for fitness to undergo chemotherapy to see how well it works in predicting treatment outcomes in older patients with cancer.
OBJECTIVES:
OUTLINE: This is a multicenter study.
All patients complete screening questionnaires (GFI, G8, and the standardized CGA which consists of the ADL (Katz index) and IADL; the Timed Up and Go; the Cancer and Leukemia Group B adaptation of Charlson Co-morbidity; the Mini Nutritional Assessment; the RAND Social Support Survey Instrument; the Folstein Mini Mental State Examination; and the Geriatric Depression Scale) before the start of anticancer treatment, prior to each course of treatment, and after 1 month of treatment. Patients also undergo physical and cognitive performance measures by a trained member of the research team. Patients are assigned to a group based on fitness for treatment. They may be reassigned after each round of assessments.
Patients' medical history, vital signs, performance status, physical examination, and body weight are obtained and recorded. In patients receiving anticancer treatment, all adverse events are graded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) and recorded and serious adverse events will be reported according to European Rules.
Ziekenhuis Netwerk Antwerpen (ZNA) is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed cancer
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Feasibility of applying screening tools (Groningen Frailty Indicator [GFI] and G8) in older patients with cancer
Comparison of the screening tools (GFI and G8) with a comprehensive geriatric assessment (CGA)
Predictive value of the screening tool to undergo standard anticancer treatment in terms of toxicity according to the NCI-CTC
This study is status unknown, as verified in May 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ziekenhuis Netwerk Antwerpen (ZNA)